Skip to content

Using Mudgaparni medicated Go ghrita Eye Drops to Manage Computer Vision Syndrome

A Randomized Controlled Clinical Study on Effect of Mudgaparni Siddha Goghrita Aschyotana in Computer Vision Syndrome - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079482
Enrollment
60
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H049- Disorder of lacrimal system, unspecified

Interventions

None listed

Sponsors

Dr Sandeep Rawat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients suffering from Computer Vision Syndrome will be selected 2 Patients will be selected irrespective of gender, socio-economic status and religion.

Exclusion criteria

Exclusion criteria: 1 Any ocular surface pathology. 2 Any ocular disease other than Computer Vision syndrome 3 Patient aged below 15 and above 45 years 4 Congenital anomalies of eye. 5 One eyed patient

Design outcomes

Primary

MeasureTime frame
Dryness of eye will be assessed Eye fatigue will be assessedTimepoint: Dryness and eye fatigue will be assessed on 7th day, 15th day and on 30th day

Secondary

MeasureTime frame
Eye redness will be assessed Burning sensation will be assessed Itching sensation will be assessed Headache will be assessedTimepoint: Eye redness, burning sensation, itching sensation & headache will be assessed also after 3 months

Countries

India

Contacts

Public ContactDr Santosh Mulik

Bharati Vidyapeeth (Deemed to be University), College of Ayurved, Pune-43

mulik.santosh@bharatividyapeeth.edu9823491389

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026